跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 38 条关于
“Supernus”
全部
38
临床试验
5
药物
0
机构
1
资讯
32
2年前
FDA Issues Complete Response Letter for Supernus' SPN-830 (Apomorphine) in Parkinson's Disease
去年
Supernus Faces Generic Competition as Third Parties File ANDA Challenges for ADHD Drug Qelbree
去年
Supernus Pharmaceuticals Acquires Sage Therapeutics for $795 Million, Strengthening Neuropsychiatry Portfolio
去年
Supernus Depression Drug SPN-820 Fails to Meet Primary Endpoint in Phase IIb Trial
去年
Supernus' SPN-820 Shows Rapid Antidepressant Effects in Phase IIa Trial
去年
Sanofi Divests 50% Stake in Consumer Health Unit; Supernus Depression Drug Falls Short in Trial
去年
Supernus Pharmaceuticals Acquires Sage Therapeutics for Up to $795 Million, Securing Postpartum Depression Drug Zurzuvae
2个月前
Supernus Marks Five Years of Qelbree: The First Novel Non-Stimulant ADHD Treatment in Over a Decade
2个月前
Eli Lilly Dominates Q1 2025 Branded Pharma Earnings with 55.5% Revenue Surge; Merck, Supernus Post Mixed Results
去年
FDA Approves Supernus' ONAPGO for Motor Fluctuations in Advanced Parkinson's Disease
第 1 页,共 4 页
上一页
下一页